Long-lasting discussion: Adverse effects of intraoperative blood loss and allogeneic transfusion on prognosis of patients with gastric cancer.

Abstract

Gastrectomy with radical lymph node dissection is the most promising treatment avenue for patients with gastric cancer. However, this procedure sometimes induces excessive intraoperative blood loss and requires perioperative allogeneic blood transfusion. There are lasting discussions and controversies about whether intraoperative blood loss or perioperative blood transfusion has adverse effects on the prognosis in patients with gastric cancer. We reviewed laboratory and clinical evidence of these associations in patients with gastric cancer. A large amount of clinical evidence supports the correlation between excessive intraoperative blood loss and adverse effects on the prognosis. The laboratory evidence revealed three possible causes of such adverse effects: anti-tumor immunosuppression, unfavorable postoperative conditions, and peritoneal recurrence by spillage of cancer cells into the pelvis. Several systematic reviews and meta-analyses have suggested the adverse effects of perioperative blood transfusions on prognostic parameters such as all-cause mortality, recurrence, and postoperative complications. There are two possible causes of adverse effects of blood transfusions on the prognosis: Anti-tumor immunosuppression and patient-related confounding factors (e.g., preoperative anemia). These factors are associated with a worse prognosis and higher requirement for perioperative blood transfusions. Surgeons should make efforts to minimize intraoperative blood loss and transfusions during gastric cancer surgery to improve patients' prognosis.

• Authors: Koki Nakanishi, Mitsuro Kanda, Yasuhiro Kodera
• Journal: World journal of gastroenterology (World J Gastroenterol) Vol. 25 Issue 22 Pg. 2743-2751 (Jun 14 2019) ISSN: 2219-2840 [Electronic] United States
• PMID: 31235997 (Publication Type: Journal Article, Review)

Topics

• Blood Loss, Surgical
• Blood Transfusion (statistics & numerical data)
• Gastrectomy (adverse effects, methods)
• Humans
• Lymph Node Excision (adverse effects, methods)
• Neoplasm Recurrence, Local (diagnosis, immunology)
• Perioperative Care (statistics & numerical data)
• Prognosis
• Stomach Neoplasms (immunology, mortality, surgery)
• Transfusion Reaction (immunology)
• Transplantation, Homologous (adverse effects)
• Tumor Escape (immunology)
• Tumor Microenvironment (immunology)